Active, not recruitingPhase 2NCT05218668
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Woolsey Pharmaceuticals
- Intervention
- Fasudil (WP-0512)(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2021 – 2029
Study locations (12)
- Neuromuscular Research Center, Phoenix, Arizona, United States
- University of Colorado, Aurora, Colorado, United States
- National Jewish Health, Denver, Colorado, United States
- Lakes Research, Miami Lakes, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- University of Kentucky, Lexington, Kentucky, United States
- Cox Medical Center, Springfield, Missouri, United States
- Hospital for Special Surgery, New York, New York, United States
- Macquarie University Hospital, Sydney, New South Wales, Australia
- Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
- Calvary Health Bethlehem Hospital, Melbourne, Victoria, Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05218668 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)